Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Dec, 25 2025
Dec, 31 2025
Sep, 27 2025
Aug, 22 2025
Jan, 9 2026